When to Start CLL Treatment with Dr. William Wierda  image

When to Start CLL Treatment with Dr. William Wierda

Nov 06, 2025
05:00PM - 06:00PM EST
Online Event
Overview

Join the HealthTree Foundation for CLL for this webinar focusing on how clinicians decide when to start treatment for CLL. This is a wonderful opportunity to learn from and ask questions to one of the leading CLL experts Dr. William Wierda.

 

Agenda
5:00 PM
Introduction
Dalton Bean

Dalton introduces the agenda of the event and our featured speaker William Wierda M.D. PhD

5:05 PM
Presentation
William Wierda M.D. PhD

Dr. Wierda talks about CLL treatment

5:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Dalton Bean

Dalton Bean

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Healthtree contact William Wierda M.D. PhD

William Wierda M.D. PhD

William Wierda, MD, PhD, is a Chronic Lymphocytic Leukemia (CLL) specialist who holds a number of roles at The University of Texas MD Anderson Cancer Centre (MDACC), Houston, TX, including Professor within the Department of Leukemia, Section Chief for CLL, and Centre and Executive Medical Director. In 1986 he graduated from the University of California with a BS in Biochemistry. In 1992 he gained his PhD in Microbiology and Immunology, and a year later his MD from the University of Health Sciences/The Chicago Medical School. Following his education in Internal Medicine and Fellowship in Hematology/Oncology, Dr Wierda moved to the MDACC as an Assistant Professor of Medicine in the Department of Leukemia in 2001, and has been conducting his clinical and translational research in CLL there ever since, becoming a Professor in 2012. He has been Principal Investigator (PI), Co-PI, or collaborator in many clinical trials, published in numerous peer-reviewed journals, and has given many lectures at national and international scientific meetings.